[1]
Dewi, P.I.S.L. et al. 2024. Renal Safety of Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B Patients: An Evidence-based Case Report. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy. 25, 2 (Aug. 2024), 187–193. DOI:https://doi.org/10.24871/2522024368.